OncoGenex Pharma (OGXI) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. FMC
10. MRSH

Go back to OncoGenex Pharma (OGXI) Reports In-Line Q1 EPS

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016

May 12, 2016 4:01 PM EDT

BOTHELL, Wash. and VANCOUVER, British Columbia, May 12, 2016 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced its first quarter 2016 financial results and provided a summary of anticipated milestones.  

Financial Results and Anticipated Near-term Milestones

As of March 31, 2016, the company's cash, cash equivalents, and short-term investments were $46.1 million compared with $55.2 million as of December 31, 2015.

Based on current expectations, OncoGenex believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its currently planned operations into the third quarter of 2017. Depending on timing of enrollment or event-driven... More